Already strongly linked to uncontrolled bleeding risks with no definitive reversal agent, Two new studies have found that Johnson & Johnson’s anticoagulant drug, Xarelto, may result in an increase in stomach bleeds and eye hemorrhaging.
Xarelto is an anticoagulant intended to prevent the formation of blood clots by blocking certain clotting proteins present in the blood. It is used to treat a type of clot called deep vein thrombosis (DVT), which can result in blood clots in the lungs (pulmonary embolism) and prevent the blood clots from forming again. Xarelto is also used to treat patients with atrial fibrillation, a heart rhythm disorder, by lowering the risk of stroke caused by blood clots, or after hip or knee replacement surgery.
Studies Linking Xarelto to Bleeding
Two physicians who examined elderly patients in their practice who had transitioned from warfarin to Xarelto conducted a study and reported their findings in the June 2015 issue of JAMA Ophthalmology. The doctors found that as soon as the patients began weaning off warfarin in favor of Xarelto, the bleeds began, and pointed out that as more patients switch from warfarin to Xarelto, clinicians should be aware of this possible side effect and be ready to warn patients about it.
A second study published in the April 2015 issue of BMJ revealed that after studying approximately 46,000 people, a twofold higher risk of stomach bleeding linked to Xarelto use as compared to warfarin could not be ruled out.
Several other studies have concluded that older patients (above age 65) were reported to have suffered the majority of the bleeds associated with Xarelto. Results presented at the American Geriatrics Society 2015 Annual Scientific Meeting revealed that 74.1 percent of the bleeding events connected with Xarelto occurred in those 75 years old or older, and fatal bleeds occurred in patients averaging 82.1 years of age. In all, new anticoagulants like Xarelto were found to increase bleeding risk in elderly patients by as much as 25 percent overall, as compared to warfarin.
Our Xarelto Attorneys can Help with Your Potential Xarelto Case–
If you or a loved one has suffered serious, uncontrollable bleeding while on Xarelto, you should speak with Childers, Schlueter & Smith today about seeking compensation. It may be the only way to alleviate the financial hardship that has been placed upon you.
Consultations are free and without obligation.